PHILIP COX: Open Payments
NPI 1720716152 · SHELBYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 34 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $59 · 2025 $622
Food & beverage: $622
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $239 |
| ABBVIE INC. | 3 | $79 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Paratek Pharmaceuticals, Inc. | 3 | $53 |
| Novo Nordisk Inc | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Exact Sciences Corporation | 2 | $30 |
| Lilly USA, LLC | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: CAPLYTA, Auvelity, VRAYLAR, Ozempic, AIRSUPRA, NUZYRA, MOUNJARO, UBRELVY.
Industry payments across TN — which companies pay providers there.
